Kossenkov, A.V.; Dawany, N.; Majumdar, S.; Chang, C.; Nichols, C.; Wysocka, M.; Piekarz, R.; Showe, M.K.; Bates, S.E.; Rook, A.H.;
et al. Cutaneous T-Cell Lymphoma: Yin-Yang Effects of Transcription Factors HLF and NFIL3 in Regulation of Malignant T-Cell Markers in the Context of HDAC Inhibitor Romidepsin Treatment. Cancers 2025, 17, 2380.
https://doi.org/10.3390/cancers17142380
AMA Style
Kossenkov AV, Dawany N, Majumdar S, Chang C, Nichols C, Wysocka M, Piekarz R, Showe MK, Bates SE, Rook AH,
et al. Cutaneous T-Cell Lymphoma: Yin-Yang Effects of Transcription Factors HLF and NFIL3 in Regulation of Malignant T-Cell Markers in the Context of HDAC Inhibitor Romidepsin Treatment. Cancers. 2025; 17(14):2380.
https://doi.org/10.3390/cancers17142380
Chicago/Turabian Style
Kossenkov, Andrew V., Noor Dawany, Sonali Majumdar, Celia Chang, Calen Nichols, Maria Wysocka, Richard Piekarz, Michael K. Showe, Susan E. Bates, Alain H. Rook,
and et al. 2025. "Cutaneous T-Cell Lymphoma: Yin-Yang Effects of Transcription Factors HLF and NFIL3 in Regulation of Malignant T-Cell Markers in the Context of HDAC Inhibitor Romidepsin Treatment" Cancers 17, no. 14: 2380.
https://doi.org/10.3390/cancers17142380
APA Style
Kossenkov, A. V., Dawany, N., Majumdar, S., Chang, C., Nichols, C., Wysocka, M., Piekarz, R., Showe, M. K., Bates, S. E., Rook, A. H., Kim, E. J., & Showe, L. C.
(2025). Cutaneous T-Cell Lymphoma: Yin-Yang Effects of Transcription Factors HLF and NFIL3 in Regulation of Malignant T-Cell Markers in the Context of HDAC Inhibitor Romidepsin Treatment. Cancers, 17(14), 2380.
https://doi.org/10.3390/cancers17142380
